Elray Resources Sells Crypto iGaming Technology to 180 Life Sciences Corp.
TL;DR
Elray Resources Inc. completes sale of proprietary technology to 180 Life Sciences Corp., gaining a 40% stake in ATNF.
Elray's technology package will assist ATNF in launching an iGaming Blockchain casino through a strategic sale and potential future partnership.
The strategic sale and potential partnership are expected to enhance Elray's financial position and open new opportunities, strengthening the company's balance sheet.
Elray's Crypto iGaming solution offers gaming content from over 30 leading publishers, presenting players with the latest crypto games, slots, tables, live, sportsbook, and competition products.
Found this article helpful?
Share it with your network and spread the knowledge!

Elray Resources Inc. (OTCPK:ELRA) has announced a significant strategic sale of its proprietary technology to 180 Life Sciences Corp. (NASDAQ:ATNF), marking a pivotal moment in the company's growth trajectory. The transaction, which involves the exchange of Elray's technology for convertible preferred stock and warrants, could potentially result in Elray acquiring a 40% stake in the NASDAQ-listed 180 Life Sciences Corp.
The deal includes preferred stock convertible into a 40% stake in ATNF and warrants to purchase 3 million shares of ATNF common stock, subject to stockholder approval. This technology transfer is expected to facilitate ATNF's entry into the iGaming Blockchain casino market, leveraging Elray's expertise in the field.
Vincent Cai, CTO of Elray Resources, emphasized the strategic importance of this sale, stating that it is expected to enhance the company's financial position and support future innovation. The transaction is also anticipated to create new opportunities and revenue streams for Elray, potentially leading to collaborations with leading market players.
This development is significant for several reasons. Firstly, it represents a major financial boost for Elray Resources, potentially strengthening its balance sheet and providing resources for future growth and innovation. Secondly, the deal opens up new avenues for Elray in the rapidly evolving iGaming and blockchain sectors, positioning the company to capitalize on emerging trends in these industries.
The iGaming industry, particularly when combined with blockchain technology, is experiencing significant growth and innovation. Elray's technology stack, which will now be utilized by 180 Life Sciences Corp., includes tools and features for operating and maintaining an iGaming Blockchain operation. This could potentially lead to the development of new, cutting-edge gaming platforms that leverage the security and transparency benefits of blockchain technology.
For investors and industry observers, this deal signifies the increasing convergence of traditional gaming companies with blockchain technology firms. It also highlights the value of specialized iGaming technology in today's market, where online gaming and cryptocurrency integration are becoming increasingly prevalent.
As the iGaming industry continues to evolve, strategic moves like this one by Elray Resources could set new precedents for how gaming companies position themselves in the market. The potential for future announcements of new operator relationships, as hinted by Cai, suggests that this deal may be just the beginning of a broader strategic shift for Elray.
Curated from NewMediaWire

